Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 73 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients with Advanced/Metastatic Solid Tumors with HER2 Alterations: A Phase Ia Dose-Escalation Study
John V Heymach,Frans Opdam,Minal Barve,Hai-Yan Tu,Yi-Long Wu,David Berz, Lukas Schröter, Yanick Botilde, Behbood Sadrolhefazi, Josep Serra,Kiyotaka Yoh,Noboru Yamamoto
Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 11 (2025): 1337-1347
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 73

#Citation: 1497

H-Index: 21

G-Index: 38

Sociability: 6

Diversity: 3

Activity: 25

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn